CARDIOME PHARMA CORP's ticker is and the CUSIP is 14159U951. A total of 1 filers reported holding CARDIOME PHARMA CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $136,000 | +51.1% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $90,000 | +429.4% | 30,000 | +376.2% | 0.00% | – |
| Q4 2016 | $17,000 | -89.9% | 6,300 | -88.3% | 0.00% | -100.0% |
| Q3 2016 | $169,000 | +668.2% | 53,900 | +1183.3% | 0.00% | – |
| Q2 2016 | $22,000 | -72.2% | 4,200 | -56.7% | 0.00% | -100.0% |
| Q4 2015 | $79,000 | -80.3% | 9,700 | -79.6% | 0.00% | -83.3% |
| Q3 2015 | $401,000 | -52.8% | 47,500 | -47.4% | 0.01% | -50.0% |
| Q2 2015 | $850,000 | +1316.7% | 90,300 | +1289.2% | 0.01% | +1100.0% |
| Q1 2015 | $60,000 | +900.0% | 6,500 | +983.3% | 0.00% | – |
| Q4 2014 | $6,000 | -96.7% | 600 | -97.0% | 0.00% | -100.0% |
| Q3 2014 | $181,000 | -75.4% | 20,300 | -78.3% | 0.00% | -72.7% |
| Q2 2014 | $737,000 | +191.3% | 93,600 | +192.5% | 0.01% | +175.0% |
| Q1 2014 | $253,000 | +27.1% | 32,000 | 0.0% | 0.00% | +33.3% |
| Q4 2013 | $199,000 | +87.7% | 32,000 | +6.7% | 0.00% | +50.0% |
| Q3 2013 | $106,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 53,900 | $169,000 | 0.00% |